The effect of cidofovir on cytomegalovirus-induced hearing loss in a guinea pig model

Archives of Otolaryngology - Head and Neck Surgery

Volumn 132, Issue 6, 2006, Pages 608-615

  White, David R ^a   Choo, Daniel I ^b   Stroup, Greg ^b   Schleiss, Mark R ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COCHLEA; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG EFFECT; EVOKED BRAIN STEM AUDITORY RESPONSE; FIBROSIS; GUINEA PIG; HEARING LOSS; HISTOPATHOLOGY; IMMUNE RESPONSE; NONHUMAN; TEMPORAL BONE; VIRUS INDUCTION;

ANIMALS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; CYTOSINE; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY; GUINEA PIGS; HEARING LOSS; PHOSPHONIC ACIDS; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33745272854     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.132.6.608     Document Type: Article

References (25)

1. Demmler GJ. Infectious Diseases Society of America and Centers for Disease Control: summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis. 1991;13:315-329.
2. Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol. 2000;11:283-290.
3. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997;130:624-630.
4. Hicks T, Fowler K, Richardson M, Dahle A, Adams L, Pass R. Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr. 1993;123:779-782.
5. Kimberlin DW, Lin CY, Sanchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16-25.
6. Schleiss MR, Lacayo J. The guinea pig model of congenital cytomegalovirus infection. In: Reddehase MJ, ed. Cytomegaloviruses: Pathogenesis, Molecular Biology and Infection Control. Wymondham. Norfolk, England: Horizon Scientific Press Ltd; 2005.
7. Woolf NK, Ochi JW, Silva EJ, Sharp PA, Harris JP, Richman DD. Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis. Antimicrob Agents Chemother. 1988;32:865-872.
8. Fox DS, Schleiss MR. Sequence and transcriptional analysis of the guinea pig cytomegalovirus UL97 homolog. Virus Genes. 1997;15:255-264.
9. Lalezari JP, Drew WL, Glutzer E, et al. (S)-1-[3-hydroxy-2- (phosphonylmethoxy) propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis. 1995;171:788-796.
10. Platzbecker U, Bandt D, Thiede C, et al. Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation. Transplantation. 2001;71:880-885.
11. Neyts J, Sobis H, Snoeck R, Vandeputte M, De Clercq E. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2- propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice. Eur J Clin Microbiol Infect Dis. 1993;12:269-279.
12. Neyts J, Balzarini J, Naesens L, De Clercq E. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2- propoxymethyl) guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice. J Med Virol. 1992;37:67-71.
13. Neyts J, Snoeck R, Balzarini J, De Clercq E. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl) cytosine (HPMPC) in vitro. Antiviral Res. 1991;16:41-52.
14. Lalezari JP, Stagg RJ, Kuppermann BD, et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: a randomized, controlled trial. Ann Intern Med. 1997;126:257-263.
15. Berenguer J, Mallolas J; Spanish Cidofovir Study Group. Intravenous cidofovir for compassionate use in AIDS patients with cytomegalovirus retinitis. Clin Infect Dis. 2000;30:182-184.
16. Bourne N, Bravo FJ, Bernstein DI. Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals. Antiviral Res. 2000;47:103-109.
17. Cundy KC, Barditch-Crovo P, Petty BG, et al. Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 1999;43:271-277.
18. Schleiss MR, Bernstein DI, McVoy MA, et al. The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs. Antiviral Res. 2005;65:35-43.
19. Schleiss MR, Bourne N, Stroup G, et al. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine. J Infect Dis. 2004;189:1374-1381.
20. Yow MD, Demmler GJ. Congenital cytomegalovirus disease - 20 years is long enough. N Engl J Med. 1992;326:702-703.
21. Woolf NK. Experimental congenital cytomegalovirus labyrinthitis and sensorineural hearing loss. Am J Otolaryngol. 1990;11:299-303.
22. Harris JP, Woolf NK, Ryan AF, Butler DM, Richman DD. Immunologic and electrophysiological response to cytomegaloviral inner ear infection in the guinea pig. J Infect Dis. 1984;150:523-530.
23. Woolf NK, Harris JP, Ryan AF, Butler DM, Richman DD. Hearing loss in experimental cytomegalovirus infection of the guinea pig inner ear: prevention by systemic immunity. Ann Otol Rhinol Laryngol. 1985;94:350-356.
24. Rarey KE, Davis LE. Temporal bone histopathology 14 years after cytomegalic inclusion disease: a case study. Laryngoscope. 1993;103:904-909.
25. Nomura Y, Hara M, Kurata T. Experimental herpes simplex virus and cytomegalovirus labyrinthitis. Acta Otolaryngol Suppl. 1989;457:57-66.